Ray Dalio’s Idexx Laboratories IDXX Stock Holding History

Ray Dalio’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.8M	Buy	10,314 +4,156	+67%	+$2.67M	0.03%	390
2025 Q4	$4.17M	Sell	6,158 -1,246	-17%	-$849K	0.02%	585
2025 Q3	$4.73M	Buy	7,404 +4,779	+182%	+$2.9M	0.02%	507
2025 Q2	$1.41M	Sell	2,625 -809	-24%	-$387K	0.01%	447
2025 Q1	$1.44M	Sell	3,434 -5,427	-61%	-$2.36M	0.01%	485
2024 Q4	$3.66M	Sell	8,861 -3,888	-30%	-$1.71M	0.02%	385
2024 Q3	$6.44M	Sell	12,749 -19,677	-61%	-$9.56M	0.04%	330
2024 Q2	$15.8M	Sell	32,426 -2,099	-6%	-$1.05M	0.08%	183
2024 Q1	$18.6M	Sell	34,525 -24,337	-41%	-$13.3M	0.09%	164
2023 Q4	$32.7M	Sell	58,862 -57,969	-50%	-$27.2M	0.18%	97
2023 Q3	$51.1M	Buy	116,831 +9,096	+8%	+$4.54M	0.31%	65
2023 Q2	$54.1M	Buy	107,735 +4,363	+4%	+$2.09M	0.33%	63
2023 Q1	$51.7M	Sell	103,372 -17,392	-14%	-$8.32M	0.32%	65
2022 Q4	$49.3M	Sell	120,764 -23,409	-16%	-$9.09M	0.27%	75
2022 Q3	$47M	Buy	144,173 +6,972	+5%	+$2.56M	0.24%	85
2022 Q2	$48.1M	Sell	137,201 -2,240	-2%	-$913K	0.2%	103
2022 Q1	$76.3M	Buy	139,441 +35,770	+35%	+$18.8M	0.31%	59
2021 Q4	$68.3M	Buy	103,671 +15,166	+17%	+$9.52M	0.4%	46
2021 Q3	$55M	Buy	88,505 +17,821	+25%	+$12M	0.3%	61
2021 Q2	$44.6M	Buy	70,684 +28,974	+69%	+$16M	0.29%	70
2021 Q1	$20.4M	Sell	41,710 -1,027	-2%	-$515K	0.18%	104
2020 Q4	$21.4M	Buy	42,737 +21,984	+106%	+$9.84M	0.18%	83
2020 Q3	$8.16M	Buy	+20,753	New	+$7.67M	0.1%	97
2020 Q2	–	Sell	-2,702	Closed	-$655K	–	449
2020 Q1	$655K	Buy	+2,702	New	+$705K	0.01%	255
2019 Q4	–	Sell	-3,646	Closed	-$991K	–	527
2019 Q3	$991K	Buy	+3,646	New	+$1.01M	0.01%	227
2019 Q1	–	Sell	-8,348	Closed	-$1.55M	–	403
2018 Q4	$1.55M	Buy	+8,348	New	+$1.71M	0.01%	278
2018 Q3	–	Sell	-2,501	Closed	-$545K	–	415
2018 Q2	$545K	Sell	2,501 -2,994	-54%	-$617K	0.01%	352
2018 Q1	$1.05M	Buy	+5,495	New	+$1.01M	0.01%	261
2017 Q4	–	Sell	-1,743	Closed	-$271K	–	285
2017 Q3	$271K	Buy	+1,743	New	+$276K	﹤0.01%	276
2015 Q4	–	Sell	-7,826	Closed	-$581K	–	342
2015 Q3	$581K	Buy	7,826 +3,600	+85%	+$258K	0.01%	311
2015 Q2	$271K	Buy	+4,226	New	+$293K	﹤0.01%	297
2014 Q4	–	Sell	-14,226	Closed	-$838K	–	381
2014 Q3	$838K	Buy	+14,226	New	+$899K	0.01%	235
2014 Q2	–	Sell	-4,602	Closed	-$279K	–	337
2014 Q1	$279K	Buy	+4,602	New	+$274K	﹤0.01%	313

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ray Dalio's IDXX Position: Q1 2026 in Review

Ray Dalio increased its Idexx Laboratories (IDXX) stake by 67% in Q1 2026, buying an estimated $2.67M and bringing the position to 10,314 shares worth $5.8M. The position accounts for 0.03% of the portfolio, ranked #390.

Ray Dalio first reported a position in IDXX in Q1 2014 and has held it in 33 quarters since. The position peaked at $76.3M in Q1 2022. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Ray Dalio held 10,314 shares of Idexx Laboratories worth $5.8M as of Q1 2026.
Ray Dalio bought 4,156 Idexx Laboratories shares in Q1 2026, an estimated $2.67M.
Idexx Laboratories made up 0.03% of Ray Dalio's portfolio in Q1 2026, its #390 holding.
Ray Dalio first reported a position in Idexx Laboratories in Q1 2014 and has held it in 33 quarters since.
Ray Dalio's Idexx Laboratories position peaked at $76.3M in Q1 2022.
1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.